Sanofi Consumer Healthcare India enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Dec 2025FY25Dec 2024
7,642——
375375327
7,268——
−375−375−327
₹3,159.84——
384384273
7.42×——
19.66×——
20.38×——
26.94×——
Reference items — trailing FY values
979878725
370309271
357297266
—277439
270270429
—269398
—7.69.9
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

SANOFICONR₹3,322.80

Sanofi Consumer Healthcare India Limited

· Pharma & Health
₹ CrorePeersPGHLSANOFISENORESINNOVACAPMOREPENLABIOLCPFDCASTRAZENMcap ₹7,642 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY25
31/12/2024
FY26
31/12/2025
Current/LTM
TTM · last close
Market Capitalization——7,642.4
- Cash, Equiv & ST Investments326.9374.8374.8
Enterprise Value——7,267.6
Net Debt (memo)-326.9-374.8-374.8
EV per Share——3,159.84
Total Capital273.0384.0384.0
EV/Sales——7.42
EV/EBITDA——19.66
EV/EBIT——20.38
EV/Free Cash Flow——26.94
Reference Items — Trailing FY Values
Sales724.5878.4979.0
EBITDA270.6309.0369.6
EBIT266.1297.3356.6
Operating Cash Flow439.0277.4—
Free Cash Flow429.1269.8269.8
FCFF (free cash flow to the firm)398.4269.3—
Capital Expenditure9.97.6—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.